Cello is an insight and strategic marketing group, listed on London’s AIM.
Cello is comprised of two distinct businesses: Cello Health and Cello Signal. Cello Health delivers cutting-edge professional marketing services to the global pharmaceutical and health sectors. Cello Signal delivers technically-led insight and marketing support services to global consumer and business-to-business clients.
Cello’s overall mission is to cut through the increasing clutter of market data and discover the real value of market information, allowing our clients across both of our businesses to make faster and better market decisions.
Cello delivers its services from office networks in the UK, USA, Singapore and Hong Kong, through a group of over 800 professionals.
Closing share price
|FY, 2013||FY, 2014||FY, 2015|
|£159.7 m||£77 m||£156.4 m|
Revenue growth, %
Cost of sales
|£85 m||£88.9 m||£70.6 m|
Operating expense total
|£68.7 m||£76.8 m||£81.5 m|